NEKTAR THERAPEUTICS's ticker is and the CUSIP is 640268908. A total of 5 filers reported holding NEKTAR THERAPEUTICS in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,360 | -42.1% | 9,000 | -44.1% | 0.00% | – |
| Q2 2023 | $9,261 | +105.8% | 16,100 | +151.6% | 0.00% | – |
| Q1 2023 | $4,499 | -23.4% | 6,400 | +146.2% | 0.00% | – |
| Q4 2022 | $5,876 | -98.6% | 2,600 | -98.0% | 0.00% | -100.0% |
| Q3 2022 | $423,000 | -37.7% | 132,100 | -26.1% | 0.00% | 0.0% |
| Q2 2022 | $679,000 | -48.4% | 178,700 | -26.8% | 0.00% | 0.0% |
| Q1 2022 | $1,315,000 | +10.1% | 244,000 | +176.0% | 0.00% | 0.0% |
| Q4 2021 | $1,194,000 | -1.1% | 88,400 | +31.5% | 0.00% | 0.0% |
| Q3 2021 | $1,207,000 | +195.8% | 67,200 | +182.4% | 0.00% | – |
| Q2 2021 | $408,000 | -35.2% | 23,800 | -24.4% | 0.00% | -100.0% |
| Q1 2021 | $630,000 | -61.6% | 31,500 | -67.3% | 0.00% | -66.7% |
| Q4 2020 | $1,639,000 | -25.7% | 96,400 | -27.5% | 0.00% | -57.1% |
| Q3 2020 | $2,206,000 | -30.2% | 133,000 | -2.5% | 0.01% | -53.3% |
| Q2 2020 | $3,159,000 | +50.5% | 136,400 | +16.0% | 0.02% | -11.8% |
| Q1 2020 | $2,099,000 | -38.0% | 117,600 | -25.0% | 0.02% | -26.1% |
| Q4 2019 | $3,387,000 | +119.2% | 156,900 | +85.0% | 0.02% | +91.7% |
| Q3 2019 | $1,545,000 | -26.0% | 84,800 | +44.5% | 0.01% | -36.8% |
| Q2 2019 | $2,089,000 | +816.2% | 58,700 | +763.2% | 0.02% | +533.3% |
| Q1 2019 | $228,000 | -93.3% | 6,800 | -93.5% | 0.00% | -90.0% |
| Q4 2018 | $3,425,000 | -52.5% | 104,200 | -11.9% | 0.03% | -47.4% |
| Q3 2018 | $7,212,000 | -13.7% | 118,300 | -30.9% | 0.06% | -19.7% |
| Q2 2018 | $8,355,000 | +16.0% | 171,100 | +152.4% | 0.07% | -1.4% |
| Q1 2018 | $7,204,000 | +11.4% | 67,800 | -37.4% | 0.07% | +60.0% |
| Q4 2017 | $6,468,000 | +294.6% | 108,300 | +58.6% | 0.04% | +200.0% |
| Q3 2017 | $1,639,000 | +296.9% | 68,300 | +223.7% | 0.02% | +275.0% |
| Q2 2017 | $413,000 | -67.5% | 21,100 | -61.1% | 0.00% | -73.3% |
| Q1 2017 | $1,272,000 | +82.8% | 54,200 | -4.4% | 0.02% | +114.3% |
| Q4 2016 | $696,000 | +57.5% | 56,700 | +120.6% | 0.01% | +40.0% |
| Q3 2016 | $442,000 | -3.3% | 25,700 | -19.9% | 0.01% | 0.0% |
| Q2 2016 | $457,000 | +68.6% | 32,100 | +62.9% | 0.01% | +25.0% |
| Q1 2016 | $271,000 | -54.5% | 19,700 | -44.2% | 0.00% | -42.9% |
| Q4 2015 | $595,000 | +41.3% | 35,300 | -8.1% | 0.01% | +16.7% |
| Q3 2015 | $421,000 | -69.3% | 38,400 | -65.0% | 0.01% | -68.4% |
| Q2 2015 | $1,372,000 | +18.9% | 109,700 | +4.6% | 0.02% | +5.6% |
| Q1 2015 | $1,154,000 | +510.6% | 104,900 | +759.8% | 0.02% | +500.0% |
| Q4 2014 | $189,000 | -41.3% | 12,200 | -54.3% | 0.00% | -40.0% |
| Q3 2014 | $322,000 | -14.8% | 26,700 | -9.5% | 0.01% | -16.7% |
| Q2 2014 | $378,000 | +65.1% | 29,500 | +56.1% | 0.01% | +50.0% |
| Q1 2014 | $229,000 | -38.3% | 18,900 | -42.2% | 0.00% | -33.3% |
| Q4 2013 | $371,000 | -67.5% | 32,700 | -70.1% | 0.01% | -72.7% |
| Q3 2013 | $1,142,000 | +237.9% | 109,300 | +273.0% | 0.02% | +175.0% |
| Q2 2013 | $338,000 | – | 29,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 36,600 | $139,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 178,700 | $679,000 | 0.00% |
| SIMPLEX TRADING, LLC | 245,500 | $932,000 | 0.00% |
| JANE STREET GROUP, LLC | 160,000 | $608,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |